NCT00806221View on ClinicalTrials.gov

An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2009

Conditions
Atopic Dermatitis
Interventions
DRUG

emollient (Cetaphil cream)

Cetaphil cream applied daily from birth

Trial Locations (1)

97239

Oregon Health & Science University, Department of Dermatology, Portland

Sponsors

Collaborators (1)

Galderma R&D
All Listed Sponsors
collaborator

Galderma R&D

INDUSTRY

lead

Oregon Health and Science University

OTHER